Prosus Ventures.
The most aggressive buyer in Indian digital: $7bn+ deployed since 2005, four portfolio IPOs in thirteen months, 22% of Swiggy and 26% of Rapido, and a CEO target to 5x the India portfolio to $50bn.
GW GP Score
Prosus is permanent balance-sheet capital running an ecosystem strategy no fund can copy: PayU processes payments for Swiggy, lends with Meesho, and the group buys into listed small-caps (ixigo at 15.2%) as readily as private rounds. FY26 was the inflection: India revenue $781M and adjusted-EBITDA positive for the first time, and the response was to buy MORE: $240M into Rapido, Swiggy's Rapido stake taken out entirely, Urban Company doubled pre-IPO. The Accel Day-Zero alliance bolts an early-stage AI funnel onto a late-stage machine. BYJU'S is the write-off scar the model carries.
Re-up candidate: the realised-cash evidence is doing more work than the brand story.
Portfolio quality depends on a narrow theme; the right comp is concentration risk, not headline unicorn count.
No named analyst override yet; current view is generated from the scored dossier and should be refreshed when the next primary source lands.
Jar ~$50M round, in talks, unconfirmed.
Rapido IPO preparation: the book's next flagship listing.
Concentration cuts both ways: BYJU'S proved a single position can vaporise; Swiggy's q-commerce burn still offsets the ecosystem's gains.
Computed from current dossier sources; analyst override pending.
The largest, best-audited, and currently most aggressive institutional book in Indian digital: top of the league on evidence, with concentration (BYJU'S precedent) as the standing caveat.
22% Swiggy, 11% Meesho, 26% Rapido, PayU owned: the deepest consumer-digital book in India
>$500M Swiggy OFS + audited FV gains; deliberately under-harvested
Ecosystem + listed-smallcap + Accel AI funnel: three lanes nobody else combines
Permanent capital deploying $650M+/yr with a stated 5x ambition
Bloisi era energetic; Sharma continuity; strategy discontinuity risk sits at group level
Portfolio quality 25% · Exit realisation 30% · Sector positioning 15% · Capital velocity 15% · Franchise stability 15%: see the full GP Score methodology · compare this firm →
Positive catalysts and/or re-up evidence exceed the visible risks, but the score should move only after the named proof lands.
Swiggy liquidity clears with credible OFS/block-sale evidence.
Rapido IPO preparation: the book's next flagship listing.
Jar ~$50M round, in talks, unconfirmed.
You can't commit to Prosus, but you're competing with it: any growth round it wants, it can pre-empt with permanent capital and ecosystem synergies. Its FY26 disclosures are also the best free dataset on Indian consumer-digital unit economics.
Concentration cuts both ways: BYJU'S proved a single position can vaporise; Swiggy's q-commerce burn still offsets the ecosystem's gains.
Jar ~$50M round, in talks, unconfirmed.
Coverage initiated: inaugural GW GP Score.
Catalyst exposure · latest source pressure
Recent public evidence mapped to this GP. Read this before reading the position table: it is where the score can move next.
Keep the file warm; current events cut both ways or are not yet material enough to move score.
Attribution1 positive catalyst(s), 0 pressure catalyst(s); top driver: India PE-VC value down 5% YoY in H1 CY2026.
The broad private-capital backdrop is selective rather than euphoric; fundraising and mark support now need firm-specific proof.
Score pressureRaises the bar for weak-DPI managers and stale flagship vehicles; rewards funds with fresh closes or visible exits.
Separate broad PE-VC softness from venture AI strength before changing sector-positioning scores.
The funds
$7bn+ deployed in digital India · balance sheet across 2 tracked vehicles.
| Vehicle | Vintage | Size | Stage | Note |
|---|---|---|---|---|
| Balance sheet (Prosus NV / MIH entities) | evergreen | $7bn+ deployed | Growth → listed | No external LPs; Amsterdam-listed permanent capital |
| Prosus-Accel Atoms X alliance | 2025Recovery / IPO window | Day-Zero co-invest | Pre-seed AI/deeptech | Prosus matches Accel's cheque |
Closest booksTrifecta Capital (4 shared) · Elevation Capital (4 shared) · Bessemer India (3 shared)computed · E
Fund analytics · LP underwriting screen
Computed from the public dossier: vehicle cadence, realised exits, mark drift, concentration and franchise stability. All computed signals are GW estimates.
Vehicle cadence is neither freshly restocked nor visibly stale.
Next liquiditySwiggy · Urban Company · BlueStone · Mintifi · Captain Fresh
2 visible exit events since Jul 2024.
Vehicle cadence is neither freshly restocked nor visibly stale.
11 up / 0 flat / 1 down tracked signals.
No senior departure flagged in key people.
11 up / 0 flat / 1 down
2 events since Jul 2024
Largest tracked active exposure
Higher spread = less balanced franchise
Marked overhangPharmEasy: names with negative 12-month mark or momentum signals in the reconstructed book.
Exit-led repricing; entry discipline decisive
22.31% held; sold >$500M in the Nov 2024 IPO, held the rest
Doubled to 7.35% pre-IPO; did not sell at listing
Held through the Aug 2025 listing
10.65% at $750M: B2B supply-chain finance
Follow-on Jan 2025 with Tiger, Accel; IPO-track
At least one cited source is dated 2026.
2 visible events tracked.
12 representative positions tracked.
No departure signal structured.
Fund-level DPI/TVPI is usually not public; proxy remains estimated.
Peer median 2 · +0
Peer median 2 · +3
Peer median 74 · +2
Peer median 62 · +22
Peer median 0 · +0
Diligence agenda · how this view can change
The live research question, the proof required, and the source standard. This prevents a GP score from becoming a stale label.
Team data, Performance proxy evidence remains low-confidence despite a scored dossier.
Current · At least one cited source is dated 2026.
Upgrade the weak fields with dated facts before the next score action: Team data, Performance proxy.
Prioritise filings and firm disclosures; mark estimates as GW E until then.
Rapido IPO preparation: the book's next flagship listing.
Swiggy: next public-market or secondary print
Evidence quality · source file health
How hard the public record is beneath this view: source mix, freshness, low-confidence fields and the next source action.
Low-confidence fields: Team data, Performance proxy.
6 total sources · 33% primary
At least one cited source is dated 2026.
Prosus: FY2026 media release (firm)
Upgrade Team data evidence before changing the score.
Source tiering follows Gravitywell policy: primary = filing/regulator/company disclosure, secondary = reputable media or research, E = Gravitywell estimate. Evidence score is a GW control metric, not an external rating.
The position book
20+ significant India positions. 12 tracked below.
| Company | Sector | Entered | Entry stage | Status | 12-mo signal | Latest read |
|---|---|---|---|---|---|---|
| Swiggy | Consumer & Commerce | 2017 | Growth | Public | ▲ | 22.31% held; sold >$500M in the Nov 2024 IPO, held the rest |
| Meesho | Consumer & Commerce | 2019 | Growth | Public | ▲ | 11.2% (~$1bn); sold only ~$7M in OFS: $831M fair-value gain booked |
| Rapido | Consumer & Commerce | 2024 | Growth (led) | Unicorn | ▲ | Led $240M at $3bn (May 2026) + bought Swiggy's entire stake (~₹1,968 Cr); ~26% |
| PayU India | Fintech | 2005 | Owned | Private | ▲ | Wholly-owned; FY26 adjusted-EBITDA profitable |
| Urban Company | Consumer & Commerce | 2021 | Growth | Public | ▲ | Doubled to 7.35% pre-IPO; did not sell at listing |
| ixigo | Consumer & Commerce | 2025 | Listed stake | Public | ▲ | 15.16% via ₹1,296 Cr preferential + Peak XV/Elevation secondary: the listed-smallcap playbook |
| BlueStone | Consumer & Commerce | 2023 | Pre-IPO | Public | ▲ | Held through the Aug 2025 listing |
| Mintifi | Fintech | 2024 | Growth ($80M) | Soonicorn | ▲ | 10.65% at $750M: B2B supply-chain finance |
| Vastu Housing Finance | Fintech | 2024 | Growth (~$100M) | Private | ▲ | 8.4% effective: affordable-housing NBFC |
| Captain Fresh | Consumer & Commerce | 2022 | Growth | Soonicorn | ▲ | Follow-on Jan 2025 with Tiger, Accel; IPO-track |
| PharmEasy | Healthcare | 2021 | Growth | Unicorn | ▼ | Legacy position, heavily marked down |
| Emergent | AI | 2026 | Series B (part.) | Private | ▲ | In the $70M SoftBank-co-invested round at $300M |
Representative tracked positions reconstructed from public disclosures: not the full book. 12-mo signal is a GW estimate of mark direction from round/exit prints (E). Ownership stakes are not shown: not reliably public.
Sector exposure · where the book leans
Share of the tracked active book by normalized sector (GW estimate): read against our sector dossiers for crowding.
New cheques · 2025-26
Net buyer while everyone else harvests: ~$650M+ of fresh India deployment in FY26 against token OFS sales. The pattern is conviction concentration: take out co-investors (Swiggy's Rapido stake), buy listed smallcaps outright (ixigo), and double down pre-IPO (Urban Company).
$3bn post; CCI-cleared Swiggy stake purchase
To 15.16%; up to 25% of proceeds earmarked for AI
Doubled to 7.35%
With Accel: matching cheques into frontier cohorts
Unconfirmed
Realisation · are LPs getting paid?
Realisations are deliberate trickles from a book being grown, not harvested: four IPOs in thirteen months and Prosus barely sold. The exit is the mark; the strategy is ownership of India's consumer-digital ecosystem through its listing decade.
Sold only ~$7M; retained 11.2% worth ~$1bn: $831M fair-value gain recognised.
Sold >$500M in the $1.3bn IPO OFS; retained ~22-25%.
First-ever positive adjusted EBITDA ($18M): the ecosystem turned
Guided five in 18 months (Dec 2024): nearly delivered
Rapido, ixigo, UC secondaries: largest net buyer in the market
~9.6% written to zero (2023-24): the model's concentration risk realised
Balance-sheet investor: no fund DPI, but the disclosures are audited: FY26 India revenue, EBITDA, per-position stakes all public. GW read: the best-documented and currently most aggressive institutional book in Indian consumer digital, with AI exposure arriving via the Accel funnel rather than own conviction. E.
What they're doing
Ecosystem compounding: PayU rails under Swiggy/Meesho/ixigo commerce: each position strengthens the others.
Buy at every layer: private growth rounds, pre-IPO secondaries, listed small-caps, IPO anchor holds.
Concentrate on winners: take out co-investors (Rapido), double pre-IPO (UC): ownership over diversification.
AI via alliance: Accel Atoms X gives Day-Zero access without building a seed practice.
What can break
Concentration cuts both ways: BYJU'S proved a single position can vaporise; Swiggy's q-commerce burn still offsets the ecosystem's gains.
The $50bn target implies paying up in a market that just repriced; discipline vs mandate tension.
Listed-stake strategy (ixigo) carries public-market beta and minority-governance limits.
Jar ~$50M round, in talks, unconfirmed.
Rapido IPO preparation: the book's next flagship listing.
Swiggy stake mechanics: 25% → 22.31% unexplained in public sources.
Pace against the $50bn portfolio target: FY27 deployment run-rate.
Point-in-time discipline: these are the open items we could not verify at the current vintage. They get resolved: confirmed, corrected or dropped, at the next monthly refresh, never silently.
The takes · one screen, three readers
You can't commit to Prosus, but you're competing with it: any growth round it wants, it can pre-empt with permanent capital and ecosystem synergies. Its FY26 disclosures are also the best free dataset on Indian consumer-digital unit economics.
Prosus is the exit AND the competition: it bought Swiggy's Rapido stake, Peak XV's ixigo shares, and pre-IPO UC blocks. Cultivate it as a secondary buyer; fear it as a term-sheet rival above Series C.
Prosus's buy-list is the demand signal for Indian consumer digital: mobility (Rapido), travel (ixigo), lending infra (Mintifi, Vastu). Where it concentrates, the listing window follows within 24 months.
Sourcing. Every figure is sourced and dated. We tier provenance: Primary (official, regulatory, exchange or company filings), Secondary (tier-1 industry research and reputable media), and GW estimate (our own reconstruction or opinion, labelled, never presented as external fact). We prefer primary where it exists, reconcile divergent prints to cited ranges, and hold every number point-in-time: dated, and never silently restated; revisions publish as dated changes.
Fact vs opinion. Facts vs opinion: market sizes, official prints, prices, named deals and agency ratings are sourced facts (Primary/Secondary). Scores, grades, purity weights, scenario paths and indicative sparkline points are Gravitywell's analytical opinion (GW estimate): labelled, not presented as external data.
GW GP Scores are research opinions, not investment advice, not a solicitation, and not an assessment under any SEBI regulation. Dossiers are compiled from public sources believed reliable; firms named did not participate and figures marked E are Gravitywell estimates. Point-in-time: dated to the vintage shown and never silently restated.